Symptoms and duration of the prodromal phase in Parkinson's disease

Movement Disorders

Volumn 12, Issue 6, 1997, Pages 871-876

  Gonera, Ed G ^a   Van't Hof, Martin ^a   Berger, Hans J C ^a   Van Weel, Chris ^a   Horstink, Martin W I M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Parkinson's disease; Preclinical phase; Prodromal symptoms

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TIME;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; MUSCULOSKELETAL DISEASES; PARKINSON DISEASE; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES;

EID: 0030668234     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120607     Document Type: Article

References (19)

1. Riederer P, Wuketich S. Time course of nigro-striatal degeneration in Parkinson's disease. J Neural Transm 1976;38:377-382.
2. Hornykiewics O, Kish SJ. Biochemical pathology of Parkinson's disease. Adv Neurol 1987;45:19-34.
3. Langston JW. Predicting Parkinson's disease. Neurology 1990;40 (suppl 3):70-74.
4. Schultz W. Recent physiological and pathophysiological aspects of Parkinsonian movement disorders: minireview. Life Sci 1984;34:2213-2223.
5. The Parkinson Study Group. Effects of Tocopherol and Deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1993;328:176-183.
6. Olanow CW, Hauser RA, Gauger L, et al. The effect of Deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol 1995;38:771-777.
7. Paulson G, Dadmehr N. Is there a premorbid personality typical for Parkinson's disease? Neurology 1991;41(suppl 2):73-76.
8. Todes CJ, Lees AJ. The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1985;48:97-100.
9. Korten JJ, Ketterings K. Anthropologische Aspekte der Parkinsonschen Krankheit. Nervenarzt 1972;43:201-205.
10. Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 1995;10:201-206.
11. Snider SR, Sandyk R. Sensory dysfunction. In:Koller W, ed. Handbook of Parkinson's Disease. New York: Marcel Dekker, Inc; 1987:171-180.
12. Schott GD. Pain in Parkinson's disease. Pain 1985;22:407-411.
13. Kinnier-Wilson SA. Neurology. Vol II. London: Edward Arnold & Co; 1940:791.
14. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1;1986:45-49.
15. Gotham AM, Brown GG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381-389.
16. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981;31:645-650.
17. Santamaria J, Tolosa E, Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986;36:1130-1133.
18. Tanner CM, Goetz CG, Klawans HL. Autonomic nervous system disorders. In: Koller W, ed. Handbook of Parkinson's Disease. New York: Marcel Dekker, Inc; 1987:145-170.
19. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:138-142.